FDA OK's Trijardy XR; Dual Hormone Artificial Pancreas

<![CDATA[]]>(MedPage Today) — The FDA approved Boehringer Ingelheim and Eli Lilly’s triple action extended release diabetes pill Trijardy XR, combining empagliflozin (Jardiance), linagliptin (Tradjenta), and metformin hydrochloride.
A dual hormone artificial…

Source link

Related posts

Global Rate of Suicide Deaths Is on the Decline


More than 150 Experts from Children's Hospital of Philadelphia Participate in the 2018 Pediatric Academic Societies Meeting


Back to School Safety: What You Need to Know About Schools and COVID-19


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World